GlassScriptPhysician profile
Mohamed Rahman
NPI 1932121571
$9,545.09
in general payments reported to CMS, 2019-2025
26 companies · $1,830 in 2025
The $1,830 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,346 · 2020: $36.75 · 2021: $160 · 2022: $110 · 2023: $1,256 · 2024: $3,806 · 2025: $1,830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,947 · Food and Beverage: $2,914 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,947.02 |
| Food and Beverage | $2,913.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,230.10 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Cds - Other, Latitude Communicator Power Supply |
| Medtronic, INC. | $1,964.76 | 2024-2025 | Venaseal |
| Cvrx, INC. | $1,109.01 | 2025 | Barostim Neo System |
| Medical Device Business Services, INC. | $787.94 | 2023 | Carto 3 |
| Abbott Laboratories | $675.47 | 2019-2025 | Ensite, Jot Dx, Assurity |
| Merck Sharp & Dohme LLC | $485.04 | 2023-2025 | Verquvo, Capvaxive |
| Biosense Webster, INC. | $377.85 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Vifor Pharma, INC. | $185.99 | 2021-2025 | Veltassa |
| Pfizer INC. | $110.69 | 2019-2025 | |
| Heartflow, INC. | $105.33 | 2025 | |
| La Jolla Pharmaceutical Company | $64.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $62.55 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $55.30 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $47.94 | 2023-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $43.64 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.99 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $40.38 | 2019-2021 | |
| Edwards Lifesciences Corporation | $26.39 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.56 | 2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $20.82 | 2023 | Inpefa |
| Eko Health, INC. | $20.00 | 2024 | |
| Biotronik INC. | $16.33 | 2024 | Biomonitor, Acticor 7 Vr-T Dx |
| Bardy Diagnostics, INC. | $15.30 | 2019 | |
| Amgen INC. | $15.01 | 2025 | Repatha |
| Elutia, INC. | $10.68 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $8.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.